S1P lyase inhibition improves post-ischemic cardiac remodeling independently of infarct size via S1P receptor 1

Back

ESC Professional Premium Access

S1P lyase inhibition improves post-ischemic cardiac remodeling independently of infarct size via S1P receptor 1

Session: Ischaemia-mediated cardiac injury: pathomechanisms and potential treatments

Topic: Ischaemia, Infarction, Cardioprotection

Speaker: Doctor M. Benkhoff (Duesseldorf, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Marcel Benkhoff

University Hospital Duesseldorf, Duesseldorf (Germany)

0 follower

5 more presentations in this session

Multidimensional immunoimaging to characterize the inflammatory reaction after permanent and temporary coronary artery occlusion in mice

Speaker: Doctor A. Maier (Freiburg, DE)

Access

Abstract

Slides

Arginase 1 in erythrocytes is a critical modulator of cardioprotective signalling by nitric oxide and soluble guanylyl cyclase

Speaker: Doctor J. Yang (Stockholm, SE)

Access

Abstract

Slides

A methylation-dependent checkpoint by SETD7 promotes myocardial ischemic injury in mice and men

Speaker: Mr S. Ambrosini (Schlieren, CH)

Access

Abstract

Slides

Agomir of miRNA-30d - a potential new therapeutic target for prevention of ischemic cardiomyopathy after myocardial infarction?

Speaker: Associate Professor M. Lichtenauer (Salzburg, AT)

Access

Abstract

Slides

Inhibition of coagulation factor XI attenuates inflammation in myocardial ischemia/reperfusion injury

Speaker: Miss Q. Luo (Mainz, DE)

Access

Abstract

Slides

Access the full session

Ischaemia-mediated cardiac injury: pathomechanisms and potential treatments

Speakers: Doctor M. Benkhoff, Doctor A. Maier, Doctor J. Yang, Mr S. Ambrosini, Associate Professor M. Lichtenauer...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources